ロード中...
Controlled Delivery of BET-PROTACs: In Vitro Evaluation of MZ1-Loaded Polymeric Antibody Conjugated Nanoparticles in Breast Cancer
Bromo and extraterminal domain (BET) inhibitors-PROteolysis TArgeting Chimera (BETi-PROTAC) is a new family of compounds that induce proteasomal degradation through the ubiquitination of the tagged to BET inhibitors Bromodomain proteins, BRD2 and BRD. The encapsulation and controlled release of BET-...
保存先:
| 出版年: | Pharmaceutics |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7589709/ https://ncbi.nlm.nih.gov/pubmed/33086530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12100986 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|